Advances in cancer immunotherapy from immune checkpoint modulation to adoptive cell transfer of tumour-infiltrating ...

CREATE Medicines, Inc. (formerly Myeloid Therapeutics) today announced new preclinical data for RetroT, the company's fully ...

diSArm clinical trial is that our phages injected intravenously can home in to the site of infection, penetrate biofilms, infect, and lyse S. aureus. Many deaths post flu, and most likely also ...

Most current approaches rely on adding nuclear localization signal (NLS) motifs to the ends of Cas9 to facilitate nuclear entry. However, this method is inefficient, and much of the Cas9 that is ...

In experiments, researchers showed that the disease-spreading insects couldn’t resist the sweet smell of a fungus that infected and killed them.

The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...

Sorghum bicolor is a deep-rooted, heat- and drought-tolerant crop that thrives on marginal lands and is increasingly valued ...

A large biobanking effort captures genetic and health data from half a million people in Taiwan, widening the diversity of ...

Seven years after the first gene-edited babies were revealed, biotech startup Manhattan Genomics is reviving the idea of ...

Flanders Institute for Biotechnology (VIB), biologist Jessie Vandierendonck has been investigating new, alternative ...

and G—that make up the genetic code. The prevailing belief was that by decoding these sequences, we could unlock how cells and organisms fundamentally work. Now, research from Northwestern Engineering ...

In a world first, a bespoke gene-editing therapy benefitted one child. Now reseachers plan to launch a clinical trial of the ...